Contact
Please use this form to send email to PR contact of this press release:
Aldeyra Therapeutics, Inc. Announces Last Patient Dosed in Allergic Conjunctivitis Phase 2b Clinical Trial
TO:
Please use this form to send email to PR contact of this press release:
Aldeyra Therapeutics, Inc. Announces Last Patient Dosed in Allergic Conjunctivitis Phase 2b Clinical Trial
TO: